![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
CM Seynaeve, MG Kazanietz, PM Blumberg, EA Sausville and PJ Worland
Laboratory of Biological Chemistry, National Cancer Institute, Bethesda, Maryland 20892.
UCN-01 (7-hydroxystaurosporine) has been demonstrated to be a potent inhibitor of tumor cell growth both in cell culture and with in vivo xenograft models. The ability of UCN-01 to inhibit the kinase activity of recombinant protein kinase C (PKC) isozymes alpha, beta, gamma, delta, epsilon, and zeta was characterized using an in vitro kinase assay. Two distinct groups of isozymes could be defined on the basis of relative potency of kinase inhibition. UCN-01 was 15-20-fold more potent for inhibition of the Ca(2+)-dependent isozymes, compared with the Ca(2+)-independent isozymes. In contrast, UCN-02 (the diastereomer of UCN-01) and staurosporine exhibited less ability to discriminate between Ca(2+)-dependent and -independent isozymes. PKC-zeta was not inhibited by UCN-01, UCN-02, or staurosporine. IC50 values for UCN-01 inhibition of the Ca(2+)-dependent PKC-alpha, -beta, and -gamma were 29, 34, and 30 nM, respectively, and for the Ca(2+)-independent PKC- delta and -epsilon were 530 and 590 nM, respectively. IC50 values for staurosporine inhibition of the isozymes alpha, beta, and gamma were 58, 65, and 49 nM, respectively, and for the isozymes delta and epsilon were 325 and 160 nM, respectively. UCN-02 was significantly less potent for the inhibition of PKC-alpha, -beta, -gamma, -delta, and -epsilon (IC50 values of 530, 700, 385, 2800, and 1200 nM, respectively). An analysis of the inhibition by UCN-01 and staurosporine of the kinase activity of PKC-alpha and -delta indicated mixed inhibition kinetics. Increasing the ATP concentration resulted in decreased potency, as shown by increased IC50 values. In contrast, increasing the peptide substrate concentration resulted in increased potency, as shown by decreased IC50 values. Increasing concentrations of myelin basic protein as a PKC-alpha or -delta substrate also caused increased potency of inhibition by UCN-01. Because of the competitive nature of inhibition with respect to ATP and the uncompetitive nature with respect to substrate, the concentrations of these substrates can have dramatically different effects on the degree of inhibition observed. These data also suggest that UCN-01 may be an important tool for the dissection of PKC isozyme contributions to signal transduction pathways.
This article has been cited by other articles:
|
|
 |
|
  V. O. Rybin, J. Guo, Z. Gertsberg, H. Elouardighi, and S. F. Steinberg Protein Kinase C{epsilon} (PKC{epsilon}) and Src Control PKC{delta} Activation Loop Phosphorylation in Cardiomyocytes J. Biol. Chem., August 10, 2007; 282(32): 23631 - 23638. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Iakoubov, A. Izzo, A. Yeung, C. I. Whiteside, and P. L. Brubaker Protein Kinase C{zeta} Is Required for Oleic Acid-Induced Secretion of Glucagon-Like Peptide-1 by Intestinal Endocrine L Cells Endocrinology, March 1, 2007; 148(3): 1089 - 1098. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. N. Tse, K. G. Rendahl, T. Sheikh, H. Cheema, K. Aardalen, M. Embry, S. Ma, E. J. Moler, Z. J. Ni, D. E. Lopes de Menezes, et al. CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons In vitro and In vivo Clin. Cancer Res., January 15, 2007; 13(2): 591 - 602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-K. Won, C.-N. Ong, and H.-M. Shen Parthenolide sensitizes ultraviolet (UV)-B-induced apoptosis via protein kinase C-dependent pathways Carcinogenesis, December 1, 2005; 26(12): 2149 - 2156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Magid and P. F. Davies Endothelial Protein Kinase C Isoform Identity and Differential Activity of PKC{zeta} in an Athero-Susceptible Region of Porcine Aorta Circ. Res., September 2, 2005; 97(5): 443 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-Q. Wu and W. C. Aird Thrombin, TNF-{alpha}, and LPS exert overlapping but nonidentical effects on gene expression in endothelial cells and vascular smooth muscle cells Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H873 - H885. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-Y. Chen, A. Doerner, P. F. Lehmann, S. Huang, G. Zhong, and Z. K. Pan A Novel Protein Kinase C (PKC{epsilon}) Is Required for fMet-Leu-Phe-induced Activation of NF-{kappa}B in Human Peripheral Blood Monocytes J. Biol. Chem., June 10, 2005; 280(23): 22497 - 22501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Sausville Indifferently Pursued or Unowned Drugs: Who Should Lead Where Companies Do Not Tread? J. Clin. Oncol., March 20, 2005; 23(9): 1796 - 1798. [Full Text] [PDF]
|
|
|
|
|
|
S. B. Kondapaka, M. Zarnowski, D. R. Yver, E. A. Sausville, and S. W. Cushman 7-Hydroxystaurosporine (UCN-01) Inhibition of Akt Thr308 but not Ser473 Phosphorylation: A Basis for Decreased Insulin-Stimulated Glucose Transport Clin. Cancer Res., November 1, 2004; 10(21): 7192 - 7198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. Dasmahapatra, P. Didolkar, M. C. Alley, S. Ghosh, E. A. Sausville, and K. K. Roy In vitro Combination Treatment with Perifosine and UCN-01 Demonstrates Synergism against Prostate (PC-3) and Lung (A549) Epithelial Adenocarcinoma Cell Lines Clin. Cancer Res., August 1, 2004; 10(15): 5242 - 5252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gassel, C. B. Breitenlechner, N. Konig, R. Huber, R. A. Engh, and D. Bossemeyer The Protein Kinase C Inhibitor Bisindolyl Maleimide 2 Binds with Reversed Orientations to Different Conformations of Protein Kinase A J. Biol. Chem., May 28, 2004; 279(22): 23679 - 23690. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Facchinetti, A. De Siervi, D. Toskos, and A. M. Senderowicz UCN-01-Induced Cell Cycle Arrest Requires the Transcriptional Induction of p21waf1/cip1 by Activation of Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase/Extracellular Signal-Regulated Kinase Pathway Cancer Res., May 15, 2004; 64(10): 3629 - 3637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zheng, R. L. Chang, X.-X. Cui, G. E. Avila, S. Lee, Y. P. Lu, Y. R. Lou, W. J. Shih, Y. Lin, K. Reuhl, et al. Inhibitory Effect of 12-O-Tetradecanoylphorbol-13-acetate Alone or in Combination with All-trans-Retinoic Acid on the Growth of LNCaP Prostate Tumors in Immunodeficient Mice Cancer Res., March 1, 2004; 64(5): 1811 - 1820. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ravandi, M. Talpaz, and Z. Estrov Modulation of Cellular Signaling Pathways: Prospects for Targeted Therapy in Hematological Malignancies Clin. Cancer Res., February 1, 2003; 9(2): 535 - 550. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Okubo, J. M. Lehman, and T. D. Friedrich Negative Regulation of Mitotic Promoting Factor by the Checkpoint Kinase Chk1 in Simian Virus 40 Lytic Infection J. Virol., December 20, 2002; 77(2): 1257 - 1267. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Patel, T. Lahusen, C. Leethanakul, T. Igishi, M. Kremer, L. Quintanilla-Martinez, J. F. Ensley, E. A. Sausville, J. S. Gutkind, and A. M. Senderowicz Antitumor Activity of UCN-01 in Carcinomas of the Head and Neck Is Associated with Altered Expression of Cyclin D3 and p27KIP1 Clin. Cancer Res., November 1, 2002; 8(11): 3549 - 3560. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Yu, J. La Rose, H. Zhang, H. Takemura, K. W. Kohn, and Y. Pommier UCN-01 Inhibits p53 Up-Regulation and Abrogates {gamma}-Radiation-induced G2-M Checkpoint Independently of p53 by Targeting Both of the Checkpoint Kinases, Chk2 and Chk1 Cancer Res., October 15, 2002; 62(20): 5743 - 5748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Senderowicz The Cell Cycle as a Target for Cancer Therapy: Basic and Clinical Findings with the Small Molecule Inhibitors Flavopiridol and UCN-01 Oncologist, August 1, 2002; 7(90003): 12 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. da Rocha, D.R.A. Mans, A. Regner, and G. Schwartsmann Targeting Protein Kinase C: New Therapeutic Opportunities Against High-Grade Malignant Gliomas? Oncologist, February 1, 2002; 7(1): 17 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Rahman, K. N. Anwar, S. Uddin, N. Xu, R. D. Ye, L. C. Platanias, and A. B. Malik Protein Kinase C-{delta} Regulates Thrombin-Induced ICAM-1 Gene Expression in Endothelial Cells via Activation of p38 Mitogen-Activated Protein Kinase Mol. Cell. Biol., August 15, 2001; 21(16): 5554 - 5565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hirose, M. S. Berger, and R. O. Pieper Abrogation of the Chk1-mediated G2 Checkpoint Pathway Potentiates Temozolomide-induced Toxicity in a p53-independent Manner in Human Glioblastoma Cells Cancer Res., August 1, 2001; 61(15): 5843 - 5849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Sausville, S. G. Arbuck, R. Messmann, D. Headlee, K. S. Bauer, R. M. Lush, A. Murgo, W. D. Figg, T. Lahusen, S. Jaken, et al. Phase I Trial of 72-Hour Continuous Infusion UCN-01 in Patients With Refractory Neoplasms J. Clin. Oncol., April 15, 2001; 19(8): 2319 - 2333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Montcouquiol and J. T. Corwin Intracellular Signals That Control Cell Proliferation in Mammalian Balance Epithelia: Key Roles for Phosphatidylinositol-3 Kinase, Mammalian Target of Rapamycin, and S6 Kinases in Preference to Calcium, Protein Kinase C, and Mitogen-Activated Protein Kinase J. Neurosci., January 15, 2001; 21(2): 570 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Urasaki, G. Laco, Y. Takebayashi, C. Bailly, G. Kohlhagen, and Y. Pommier Use of Camptothecin-resistant Mammalian Cell Lines to Evaluate the Role of Topoisomerase I in the Antiproliferative Activity of the Indolocarbazole, NB-506, and Its Topoisomerase I Binding Site Cancer Res., January 1, 2001; 61(2): 504 - 508. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Rahman, K. N. Anwar, and A. B. Malik Protein kinase C-zeta mediates TNF-alpha -induced ICAM-1 gene transcription in endothelial cells Am J Physiol Cell Physiol, October 1, 2000; 279(4): C906 - C914. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kitada, J. M. Zapata, M. Andreeff, and J. C. Reed Protein kinase inhibitors flavopiridol and 7-hydroxy-staurosporine down-regulate antiapoptosis proteins in B-cell chronic lymphocytic leukemia Blood, July 15, 2000; 96(2): 393 - 397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Senderowicz and E. A. Sausville Preclinical and Clinical Development of Cyclin-Dependent Kinase Modulators J Natl Cancer Inst, March 1, 2000; 92(5): 376 - 387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. H. Wilson, L. Sorbara, W. D. Figg, E. K. Mont, E. Sausville, K. E. Warren, F. M. Balis, K. Bauer, M. Raffeld, A. M. Senderowicz, et al. Modulation of Clinical Drug Resistance in a B Cell Lymphoma Patient by the Protein Kinase Inhibitor 7-Hydroxystaurosporine: Presentation of a Novel Therapeutic Paradigm Clin. Cancer Res., February 1, 2000; 6(2): 415 - 421. [Abstract] [Full Text]
|
|
|
|
 |
|
 W. Nieves-Neira, M. I. Rivera, G. Kohlhagen, M. L. Hursey, P. Pourquier, E. A. Sausville, and Y. Pommier DNA Protein Cross-Links Produced by NSC 652287, a Novel Thiophene Derivative Active Against Human Renal Cancer Cells Mol. Pharmacol., September 1, 1999; 56(3): 478 - 484. [Abstract] [Full Text]
|
|
|
|
|
|
R. Chiba, N. Nakagawa, K. Kurasawa, Y. Tanaka, Y. Saito, and I. Iwamoto Ligation of CD31 (PECAM-1) on Endothelial Cells Increases Adhesive Function of alpha vbeta 3 Integrin and Enhances beta 1 Integrin-Mediated Adhesion of Eosinophils to Endothelial Cells Blood, August 15, 1999; 94(4): 1319 - 1329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Andjelkovic, S.-M. Maira, P. Cron, P. J. Parker, and B. A. Hemmings Domain Swapping Used To Investigate the Mechanism of Protein Kinase B Regulation by 3-Phosphoinositide-Dependent Protein Kinase 1 and Ser473 Kinase Mol. Cell. Biol., July 1, 1999; 19(7): 5061 - 5072. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Rahman, M. Bando, J. Kefer, K. N. Anwar, and A. B. Malik Protein Kinase C-Activated Oxidant Generation in Endothelial Cells Signals Intercellular Adhesion Molecule-1 Gene Transcription Mol. Pharmacol., March 1, 1999; 55(3): 575 - 583. [Abstract] [Full Text]
|
|
|
|
|
|
L. Yu, L. Orlandi, P. Wang, M. S. Orr, A. M. Senderowicz, E. A. Sausville, R. Silvestrini, N. Watanabe, H. Piwnica-Worms, and P. M. O'Connor UCN-01 Abrogates G2 Arrest through a Cdc2-dependent Pathway That Is Associated with Inactivation of the Wee1Hu Kinase and Activation of the Cdc25C Phosphatase J. Biol. Chem., December 11, 1998; 273(50): 33455 - 33464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shimizu, C.-X. Cao, R.-G. Shao, and Y. Pommier Lamin B Phosphorylation by Protein Kinase Calpha and Proteolysis during Apoptosis in Human Leukemia HL60 Cells J. Biol. Chem., April 10, 1998; 273(15): 8669 - 8674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Basu The Involvement of Novel Protein Kinase C Isozymes in Influencing Sensitivity of Breast Cancer MCF-7 Cells to Tumor Necrosis Factor-alpha Mol. Pharmacol., January 1, 1998; 53(1): 105 - 111. [Abstract] [Full Text]
|
|
|
|
|
|
R.-G. Shao, C.-X. Cao, and Y. Pommier Activation of PKCalpha Downstream from Caspases during Apoptosis Induced by 7-Hydroxystaurosporine or the Topoisomerase Inhibitors, Camptothecin and Etoposide, in Human Myeloid Leukemia HL60 Cells J. Biol. Chem., December 12, 1997; 272(50): 31321 - 31325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. H. Zhu, L. Conforti, and D. E. Millhorn Expression of dopamine D2 receptor in PC-12 cells and regulation of membrane conductances by dopamine Am J Physiol Cell Physiol, October 1, 1997; 273(4): C1143 - C1150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Uribe, S. J. Keely, A. E. Traynor-Kaplan, and K. E. Barrett Phosphatidylinositol 3-Kinase Mediates the Inhibitory Effect of Epidermal Growth Factor on Calcium-dependent Chloride Secretion J. Biol. Chem., October 25, 1996; 271(43): 26588 - 26595. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Rzymkiewicz, T. Tetsuka, D. Daphna-Iken, S. Srivastava, and A. R. Morrison Interleukin-1beta Activates Protein Kinase Czeta in Renal Mesangial Cells. POTENTIAL ROLE IN PROSTAGLANDIN E2 UP-REGULATION J. Biol. Chem., July 19, 1996; 271(29): 17241 - 17246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Murohara, R. Scalia, and A. M. Lefer Lysophosphatidylcholine Promotes P-Selectin Expression in Platelets and Endothelial Cells : Possible Involvement of Protein Kinase C Activation and Its Inhibition by Nitric Oxide Donors Circ. Res., May 1, 1996; 78(5): 780 - 789. [Abstract] [Full Text]
|
|
|
|
|
|
M. G. Kazanietz, N. E. Lewin, J. D. Bruns, and P. M. Blumberg Characterization of the Cysteine-rich Region of the Caenorhabditiselegans Protein Unc-13 as a High Affinity Phorbol Ester Receptor J. Biol. Chem., May 5, 1995; 270(18): 10777 - 10783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Kroog, E. Sainz, P. J. Worland, M. A. Akeson, R. V. Benya, R. T. Jensen, and J. F. Battey The Gastrin-releasing Peptide Receptor Is Rapidly Phosphorylated by a Kinase Other Than Protein Kinase C After Exposure to Agonist J. Biol. Chem., April 7, 1995; 270(14): 8217 - 8224. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
